IVB-102

N/A

Report date: 2024/03/22 20:01:55

Base Information

Drug NameIVB-102
Drug Alias NameIVB-102
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsRetinoschisisRetinal DiseasesRetinal Degeneration +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Yinnuo Weikang Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Yinnuo Weikang Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsRetinoschisisRetinal DiseasesRetinal Degeneration
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A